AIM2 and triple-A syndrome: In summary, our data are in line with the hypothesis that cell-free DNA, derived from AAA patients triggers a proinflammatory response in macrophages by activating the AIM2 inflammasome and thus could be a driving force for the chronic inflammation observed in these patients.